Gut check: new study probes how IBS drug changes your microbiome
NCT ID NCT05995899
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how tenapanor, a drug for irritable bowel syndrome with constipation (IBS-C), changes the bacteria and chemicals in the gut. Thirty-six adults took tenapanor twice daily for 8 weeks and provided stool samples. The goal was to understand how the drug works beyond just relieving symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IBS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a postbiotic soothe irritable bowel syndrome?
- Could a new drug calm the gut and stop IBS pain?
- New enzyme blend could be the key to beating bloating
- Could your family history of celiac disease hide a wheat sensitivity?
- Hidden Gut-Brain issues common in kids with IBD, study finds
- Tailored team approach shows promise for IBS sufferers